Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
about
Double-blind comparison of phlebitis produced by cefazolin versus cephalothinMoxalactam and cefazolin: comparative pharmacokinetics in normal subjects.Pharmacology of intraperitoneal cefazolin in patients undergoing peritoneal dialysis.Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits.Bactericidal activity and pharmacology of cefazolinPharmacology of cephalothin in the biliary tract of humansClinical trial of cefonicid for treatment of skin infections.Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?Penetration of cefazolin into pleural fluidPenicillin and netilmicin in treatment of experimental enterococcal endocarditis.Cefazolin and enterobacteriaceae: rationale for revised susceptibility testing breakpoints.Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo.Newer beta-lactam antibiotics.Pharmacology of cefaclor in normal volunteers and patients with renal failure.Disk susceptibility studies with cefazolin and cephalothin.Semiautomated turbidimetric microbiological assay for determination of cefazolin.Treatment of anaerobic bacterial infections with clindamycin-2-phosphate.In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolatesClinical studies of cefazolin and comparison with other cephalosporins.In vitro studies with cefazolinComparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.
P2860
Q28338775-FFB73DEF-C225-4456-8D00-BF807570DA10Q30451388-B809320F-6520-40E0-864D-9AE88B4A83BFQ34278224-4A4FB94D-3711-4E37-B801-BDC28A4F2099Q34709868-060BA2F7-4615-47BB-8B17-37AC8F16DF75Q34986601-DDDE1820-83F3-4BEB-B79A-218C3807CE26Q35653439-27B4BBC9-B1A3-4459-987B-F8E399820EA2Q35659759-C4994B3A-80BB-40BF-B990-B3B7318626DEQ35745761-5E5F2F6D-CA67-4B8B-9663-1E170F326D3CQ35876841-B4B0FD7C-8F8C-4610-AA65-CC2AC0960724Q36463829-5D86332A-C232-4B3E-9CC9-C4DD9BF99E67Q36467838-BF03D91D-EF00-41B4-886F-533EB3736C32Q37856088-B4F8CAFB-CCB8-4651-820B-D12FC8170986Q39819128-655DC125-0378-43D9-B3E7-FD95477CAE5BQ39901563-461221F7-EF1E-4EBF-A72D-D21993A4BBF7Q40618664-FB69B628-7285-420B-9F6A-ADD80469A0A2Q40942860-D4921133-295A-4223-A74C-DDE2457073DEQ40943014-C9017DC5-5E81-4E55-9DC4-65542B906FF9Q40943057-FAB02D6B-F92A-4F5B-9080-38CF375CC78DQ40944887-11F9DC9E-A77F-44C0-9F85-08EE76BFEF46Q40945527-781E2A0D-CA19-4EB7-A367-173703D6AFBEQ40946762-5F431D2F-04EF-4A20-B70F-837F014E0CB4Q41030126-25E9F7AF-589A-44FE-84C4-D477ED86A8F8Q41031183-5AC83678-290F-4F8C-8BFB-BD943ED223A8Q53711919-85D5C310-FD15-4273-9F27-08B726C33D95
P2860
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
@ast
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
@en
type
label
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
@ast
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
@en
prefLabel
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
@ast
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
@en
P2093
P356
P1476
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
@en
P2093
P2860
P304
P356
10.1128/AAC.3.2.168
P407
P577
1973-02-01T00:00:00Z